| Title: | Role of primary and secondary care data in atrial fibrillation ascertainment: impact on risk factor associations, patient management, and mortality in UK Biobank |
| Journal: | EP Europace |
| Published: | 5 Feb 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39910980/ |
| DOI: | https://doi.org/10.1093/europace/euae291 |
Publication 14436
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
AIMS: Electronic healthcare records (EHR) are at the forefront of advances in epidemiological research emerging from large-scale population biobanks and clinical studies. Hospital admissions, diagnoses, and procedures (HADP) data are often used to identify disease cases. However, this may result in incomplete ascertainment of chronic conditions such as atrial fibrillation (AF), which are principally managed in primary care (PC). We examined the relevance of EHR sources for AF ascertainment, and the implications for risk factor associations, patient management, and outcomes in UK Biobank.</p>
METHODS AND RESULTS: UK Biobank is a prospective study, with HADP and PC records available for 230 000 participants (to 2016). AF cases were ascertained in three groups: from PC records only (PC-only), HADP only (HADP-only), or both (PC + HADP). Conventional statistical methods were used to describe differences between groups in terms of characteristics, risk factor associations, ascertainment timing, rates of anticoagulation, and post-AF stroke and death. A total of 7136 incident AF cases were identified during 7 years median follow-up (PC-only: 22%, PC + HADP: 49%, HADP-only: 29%). There was a median lag of 1.3 years between cases ascertained in PC and subsequently in HADP. AF cases in each of the ascertainment groups had comparable baseline demographic characteristics. However, AF cases identified in hospital data alone had a higher prevalence of cardiometabolic comorbidities and lower rates of subsequent anticoagulation (PC-only: 44%, PC + HADP: 48%, HADP-only: 10%, P < 0.0001) than other groups. HADP-only cases also had higher rates of death [PC-only: 9.3 (6.8, 12.7), PC + HADP: 23.4 (20.5, 26.6), HADP-only: 81.2 (73.8, 89.2) events per 1000 person-years, P < 0.0001] compared to other groups.</p>
CONCLUSION: Integration of data from primary care with that from hospital records has a substantial impact on AF ascertainment, identifying a third more cases than hospital records alone. However, about a third of AF cases recorded in hospital were not present in the primary care records, and these cases had lower rates of anticoagulation, as well as higher mortality from both cardiovascular and non-cardiovascular causes. Initiatives aimed at enhancing information exchange of clinically confirmed AF between healthcare settings have the potential to benefit patient management and AF-related outcomes at an individual and population level. This research underscores the importance of access and integration of de-identified comprehensive EHR data for a definitive understanding of patient trajectories, and for robust epidemiological and translational research into AF.</p>
19 Keywords
- Aged
- Anticoagulants
- Atrial Fibrillation
- Biological Specimen Banks
- Electronic Health Records
- Female
- Humans
- Incidence
- Male
- Middle Aged
- Primary Health Care
- Prospective Studies
- Risk Assessment
- Risk Factors
- Secondary Care
- Stroke
- Time Factors
- UK Biobank
- United Kingdom
9 Authors
- C Fielder Camm
- Adam Von Ende
- Parag R Gajendragadkar
- Guilherme Pessoa-Amorim
- Marion Mafham
- Naomi Allen
- Sarah Parish
- Barbara Casadei
- Jemma C Hopewell
1 Application
| Application ID | Title |
|---|---|
| 14568 | Elucidating the effects of cardiovascular therapies and drug targets |
Enabling scientific discoveries that improve human health